A federal judge’s decision to uphold the government’s authority to pre-approve drugmaker 340B rebate models has drawn praise from providers, [...] …
Category: Trade Association
A federal district judge last Friday allowed a key hospital trade group to intervene in Johnson & Johnson’s (J&J) lawsuit [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
With a Saturday deadline looming, Oklahoma Gov. Kevin Stitt (R) is facing pressure from dark money groups and drug industry-funded [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge has ruled that a major hospital advocacy group and two of its members can join the government [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two influential U.S. senators—each with a distinct vision of 340B reform—told health center leaders yesterday that they remained committed to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major hospital advocacy group and two of its members are seeking to intervene in a high-profile federal court case [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major hospital group is urging the Health Resources and Services Administration (HRSA) to intervene immediately against Sanofi’s proposed 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program is increasing healthcare costs for employers and driving hospital consolidation, argued panelists at a recent healthcare purchaser [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Johnson & Johnson’s (J&J’s) lawsuit challenging the federal government’s opposition to 340B rebates will test whether the Trump administration is [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical Research and Manufacturers of America (PhRMA) expressed “serious concerns” with the federal government’s opposition to Johnson & Johnson’s (J&J’s) [...] …